波士顿科学Boston Scientific Corporation (BSX) 2008年年度报告「NYSE」.pdf

《波士顿科学Boston Scientific Corporation (BSX) 2008年年度报告「NYSE」.pdf》由会员分享，可在线阅读，更多相关《波士顿科学Boston Scientific Corporation (BSX) 2008年年度报告「NYSE」.pdf（8页珍藏版）》请在三个皮匠报告上搜索。

1、n3Transformed qualityn3Revitalized the pipelinen3Streamlined the organizationn3Strengthened financial fundamentalsn3Diversified product portfolioDriving Success2008 Annual Report2008Sales by Geographic Segment(in millions)2008 2007 2006 Domestic 4,487 4,522 4,415 EMEA 1,960 1,833 1,631 Inter-Contine

2、ntal 1,534 1,449 1,299$7,981$7,804$7,345 Divested businesses 69 553 476$8,050$8,357$7,821 Sales by Product Category(in millions)2008 2007 2006 Interventional Cardiology 2,879 3,016 3,509 Cardiac Rhythm Management 2,286 2,124 1,371 Other Cardiovascular 837 839 845 Neurovascular 360 352 326 Endosurger

3、y 1,374 1,269 1,148 Neuromodulation 245 204 146$7,981$7,804$7,345 Divested businesses 69 553 476$8,050$8,357$7,821 2008Boston Scientific Corporation,One Boston Scientific Place,Natick,MA 01760-1537,508.650.8000,Copyright 2009 by Boston Scientific Corporation or its affiliates.All rights reserved.36%

4、28%11%5%17%3%56%19%25%Boston Scientifics mission is to improve the quality of patient care and the productivity of health care delivery through the development and advocacy of less-invasive medical devices and procedures.This is accomplished through the continuing refinement of existing products and

5、 procedures and the investigation and development of new technologies that can reduce risk,trauma,cost,procedure time and the need for aftercare.To Our Employees and Shareholders:Three years ago we set out to address a range of issues critical to the continued success of Boston Scientific.We identif

6、ied five key areas that required major change,and we initiated a strategy to drive that change and position the Company for the future.2008 was the year our efforts came together and created a renewed foundation for sustainable,profitable growth.We have now transformed quality,revitalized our pipeli